#Corneal Ulcer Treatment Market Demand | Explore Tumblr Posts and Blogs

techninja · 10 months

Text

Rising Adoption To Treat Ophthalmic Disorders Projected to boost growth of the Amniotic Membrane Market

The global Amniotic Membrane Market is estimated to be valued at US$ 3.62 Bn in 2023 and is expected to exhibit a CAGR of 13% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: The amniotic membrane is the innermost layer of the placenta which consists of epithelial cells, a thick basement membrane, and an avascular stroma. It possesses properties such as anti-inflammatory, anti-scarring, antimicrobial, anti-angiogenic and pain-relieving properties. This makes it ideal for use in wound healing applications including wounds, burns, ophthalmic disorders, surgical wounds etc. It acts as a biological scaffold and releases growth factors that aid in tissue regeneration. Compared to synthetic skin substitutes or skin grafts, amniotic membrane grafts have lesser probability of developing infection and rejection. With increasing cases of trauma, accidents and chronic wounds worldwide, the demand for effective wound care treatments is growing steadily. This is expected to propel the amniotic membrane market growth over the forecast period. Market key trends: One of the key trends gaining traction in the amniotic membrane market is the rising adoption of amniotic membrane for ophthalmic disorders. Amniotic membrane plays a crucial role in ocular surface reconstruction due to its anti-angiogenic, anti-inflammatory and anti-scarring properties. It is increasingly being used to treat ocular disorders like keratitis, corneal ulcers, persistent epithelial defects and corneal perforations. Also, continuous efforts by market players to develop new amniotic membrane products through advanced processing techniques like cryopreservation, lyophilization etc. is expected to drive the market growth. Development of amniotic membrane tissue engineered products for regenerative therapies is another emerging trend in the market. Porter’s Analysis Threat of new entrants: Low, as the market requires high capital investment and regulatory approvals for entering. Bargaining power of buyers: Moderate, as the presence of substitute products provides options to buyers. Bargaining power of suppliers: High, as raw materials have limited sources of supply globally. Threat of new substitutes: Moderate, as new substitutes are emerging but amniotic membrane has established use cases over years. Competitive rivalry: High, as the key players compete on the basis of quality, price and technology. Key Takeaways The global amniotic membrane market size is expected to witness high growth at a CAGR of 13% over the forecast period 2023 to 2030, due to increasing cases of ocular surface disorders. Regional analysis: North America dominates the global market currently owing to increasing healthcare expenditure and growing patients' population. However, Asia Pacific is expected to grow at the fastest pace during the forecast period with rising medical tourism and improving healthcare infrastructure in emerging countries. Key players operating in the amniotic membrane market include Smith & Nephew, Applied Biologics, Organogenesis Holdings Inc., Osiris Therapeutics, Inc., Alliqua BioMedical, Inc., Amnio Technology, LLC, Next Biosciences, Integra LifeSciences, MiMedx, LifeCell International, Human Regenerative Technologies, LLC, Amniox Medical, Inc, Skye Biologics Inc., Wright Medical, TissueTech, Katena Products, Inc., NuVision Biotherapies, Surgenex, and Ventris Medical. Key players are focused on new product launches and regulatory approvals to strengthen their market position.

0 notes

rohans18 · 1 year

Text

Corneal Ulcer Treatment Market Trends, Share, Competitive Dynamics, Demand - Forecast 2029

Global Corneal Ulcer Treatment Market, By Treatment (Medication, Surgery, Others), Diagnosis (Fluorescein Eye Stain Test, Slit-Lamp Exam, Others), Symptoms (Redness, Tears, Discharge from Eye, Blurry Vision, Swollen Eyelids, Vision Changes, Severe Pain, Others), Dosage (Eye Drops, Tablets, Others), Route of Administration (Oral, Topical, Others), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) Industry Trends and Forecast to 2029

In the consistent Corneal Ulcer Treatment market research report, industry trends are put together on macro level with which clients can figure out market landscape and possible future issues about Corneal Ulcer Treatment industry. The scope of this market report include but is not limited to latest trends, market segmentation, new market entry, industry forecasting, future directions, opportunity identification, strategic analysis and planning, target market analysis, insights and innovation. The report presents with the CAGR value fluctuations for the specific forecasted period which helps decide costing and investment strategies. An influential Corneal Ulcer Treatment market report brings precise and exact market research information that drives business into the right direction.

Key Players

Some of the major players operating in the corneal ulcer treatment market are Pfizer Inc., GlaxoSmithKline plc, Sanofi, Novartis AG, Allergan, Merck & Co., Inc., Mylan N.V., Teva Pharmaceutical Industries Ltd., Bayer AG, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, Lupin, AbbVie Inc., Cumberland Pharmaceuticals Inc., Melinta Therapeutics LLC, Eli Lilly and Company, Cipla Inc., Dr. Reddy’s Laboratories Ltd., AstraZeneca, and Johnson & Johnson Private Limited, among others.

Browse More Info @ https://www.databridgemarketresearch.com/reports/global-corneal-ulcer-treatment-market

The research studies entailed in the winning Corneal Ulcer Treatment market report supports to estimate several important aspects that includes but are not limited to investment in a rising market, success of a new product, and expansion of market share. The strategies underlined here mainly consist of new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others that boost footprints in this market. Several other factors such as import, export, gross margin, price, cost, and consumption are also analyzed under the section of production, supply, sales and market status.

Key questions answered in the report:

Which product segment will grab a lion’s share?

Which regional market will emerge as a frontrunner in coming years?

Which application segment will grow at a robust rate?

Report provides insights on the following pointers:

Market Penetration: Comprehensive information on the product portfolios of the top players in the Corneal Ulcer Treatment Market.

Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the market.

Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.

Table Of Content

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03: Global Market

Part 04: Global Market Size

Part 05: Global Market Segmentation By Product

Part 06: Five Forces Analysis

More Reports:

Diuretic Drugs Market

Patient Engagement Technology Market

Healthcare Business Intelligence Market

Chinese Hamster Ovary cells (CHO) Market

Anti-cancer Drug Market

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market

0 notes

tritonmarketresearch · 2 years

Text

Amniotic Membrane Market: Significance & Global Performance

Amniotic membrane or amnion, a thin membrane on the inner side of the fetal placenta and composed of the epithelium, has emerged as an ideal source for tissue transplantation. Moreover, amnion has an array of biological properties, making it attractive for use in various surgical procedures, including ocular surface reconstruction and tissue engineering.

The advancements in anatomy have triggered significant investments in research and development of amniotic membrane applications. While AM has shown beneficial results in burn injuries, the upsurge in R&D investments has increased its use in eye surgery, cell therapy, stem cell research, and more, boosting the amniotic membrane market growth prospects.

In fact, the identification of new stem cells has increased the membrane’s potential, making it ideal for developing regenerative medicines. For instance, Organogenesis Holdings Inc, a leading regenerative medicine company, gained approval from the US FDA for ReNu, a cryopreserved amniotic suspension allograft, to manage symptoms related to knee osteoarthritis.

Amniotic Membrane Market - Global & Regional Trends

As per estimates, the global amniotic membrane market will display revenue growth at a CAGR of 7.01% during the forecast period 2022-2028.

Considering the evolving healthcare sector, the amniotic membrane market is expected to witness tremendous growth in the Asia-Pacific nations. Estimates suggest that approximately half a billion people in the region will be 65 or older by 2025. This change in demographics, in addition to a shift in consumer expectations, will widen the market’s scope. In this regard, the growing demand for chronic care management will expand amnion application in ophthalmology, burn injuries, and cosmetic surgeries, among others.

Additionally, amniotic membrane transplantation has gained momentum in various conjunctival and corneal diseases, signaling opportunistic growth for players in the APAC region. Considering its growth in North America, amnions have proven advantageous in treating limbal stem cell deficiency, providing support and protection to transplanted limbal tissues and stem cells. Recently, in Canada, numerous techniques have been developed to dehydrate amnion while preserving the wound-healing properties to formulate a temperature-stable allograft.

Furthermore, the United Kingdom is the center of research and development of amniotic membrane applications in Europe. Several hospitals, such as NuVision, have gained expertise in providing AM treatments. Amniotic membrane treatments are gaining center stage across the nation, given the technological advancements. For instance, in November 2021, several ophthalmologists shared their innovations of AM application in treating ocular surface conditions through a webinar sponsored by NuVision Biotherapies Ltd.

Market by Application – Expert Outlook

Surgical Wounds: Human amniotic membrane has been used for treating acute and chronic wounds, decreasing infection and pain while accelerating the healing time. The surgical wound segment dominates the overall market and is expected to maintain its stronghold till 2028. Although a plethora of wound dressings are available, chronic wounds remain a major medical concern. As a result, chronic wounds awareness programs largely support amnion application. For instance, the Wound Healing and Hyperbaric Center at Carteret Health Care, a Healogic Network member, is engaged in raising awareness of chronic wounds, providing advanced therapies.

Ophthalmology: The rise in chronic and infectious diseases has resulted in a global rise in surgeries, boosting the market’s potential. Amniotic membrane is rapidly used in ophthalmic surgeries to initiate faster recovery and decrease inflammation. Amnion has become crucial in eye treatments, given its anti-scarring and anti-inflammatory properties. For instance, Bio Tissue Inc offers AmnioGraft to treat ocular surface indications like corneal ulcers, dry eye, chemical burns, etc. Besides, AM is highly preferred in developing regions since it is cheaper than allografts.

Competitive Analysis

For any company, acquisitions and agreements ensure expansion in business footings. Acquisitions, for instance, are quicker, cheaper, and less risky compared to other methods to extend volume sales. On the other hand, agreements are crucial to eliminating disagreements, confusion, or changes that may transpire during the course of the business period.

Notable acquisitions and agreements that support the market’s development:

In February 2021, Katena Products Inc, a leading provider of premium ophthalmic instruments and devices, announced the acquisition of ASICO LLC to expand the ophthalmic surgical product line and lead in the innovation of new products.

Integra LifeSciences Corporation, in January 2021, acquired ACell Inc and its proprietary MatriStem UMB to offer comprehensive wound management solutions.

Celularity Inc and Oncternal Therapeutics Inc entered into a research partnership in September 2021 to examine placental-derived cellular treatments.

Celularity also collaborated with Imugene Ltd in August 2021 to employ Imugene’s CD19 oncolytic virus technology and its CD19 CYCART-19 to remedy solid tumors.

In Conclusion,

The amniotic membrane market has shown rapid and promising results in healing damaged tissues. From chemical burns to ulcers to the cornea, amnions have emerged as suitable membranes in wound care management. This indicates that the use of AM in medicine and therapies is expanding in various branches of medicine.

#Amniotic Membrane Market #amniotic membrane #healthcare and wellness #healthcare #lifesciences #market research reports #market research report #triton market research

0 notes

researchinhealthcare · 3 years

Text

Corneal Transplant Market Professional Survey Report by 2023

Corneal Transplant Market Highlights :

Corneal transplant is a surgical procedure performed for the treatment of diseased cornea. Important indications for corneal transplant are keratoconus, keratitis, and corneal stromal dystrophies. The success rate of the treatment is found to be high, which support the market growth.

Rising prevalence of vision impartment and eye diseases such as diabetic retinopathy in geriatric population and diabetes across the globe drive the global market. Additionally, rising awareness about organ donation and its importance, especially, in the developing countries likely to propel the market growth.

Cost of corneal transplant market varies depending upon the region, availability of services, and skilled and qualified professionals. Major difference in the cost is observed, i.e. it is found to be high in the developed countries and low in developing countries still maintaining qualitative care. Therefore, cost effective of the treatment would affect the market growth.

The global corneal transplant market is expected to grow at a CAGR of 10.8% during the forecast period.

Major Players in Corneal Transplant Market:

Some of the key players in the global market are CryoLife, Inc. (U.S.), Exactech, Inc. (U.S.), Köhler GmbH (U.S.), Lifeline Scientific (U.S), LifeCell Corporation (U.S.), Medtronic (U.S.), and Organogenesis Inc. (U.S.).

Click For Free Sample Report @ https://www.marketresearchfuture.com/sample_request/4525

Corneal Transplant Market Regional Analysis :

Europe is the largest market for corneal transplant which will exhibit positive growth in the near future due to rising prevalence of diabetes in the European countries and availability of treatment options. According to the World Health Organization, about 60 million Europeans have diabetes and its prevalence is relatively high among people over 25 years.

America is the second leading corneal transplant market across the globe owing to an increasing demand for corneal transplant surgery, and rising prevalence of eye diseases, and vision impairment among people in the U.S.

Asia Pacific market is expected to grow rapidly owing increasing prevalence of chronic diseases such as diabetes, diabetic retinopathy, and obesity. India is one of the international medical tourism destinations across the world, which further exhibits growth opportunities for the corneal transplant market due to availability of cost-effective treatment and rising success rates. Furthermore, the increasing healthcare expenditure by developing countries in Asia Pacific region also contributes to the market growth.

The Middle East & African market is growing steadily owing to rising demand for ophthalmic products and services, and available treatment options.

Corneal Transplant Market Segmentation :

The global corneal transplant market is segmented on the basis of type, indication, and end user.

On the basis of type, the market is segmented into penetrating keratoplasty, endothelial keratoplasty, descemet stripping automated endothelial keratoplasty (DSAEK), corneal graft, corneal limbal stem cell transplant, and others.

On the basis of indication, the market is segmented into fungal corneal ulcer, bullous keratopathy, keratoconus, keratitis, corneal stromal dystrophies, and others.

On the basis of end user, the market is segmented into hospitals, eye clinics, and others.

Access Report Details @ https://www.marketresearchfuture.com/reports/corneal-transplant-market-4525

#Corneal Transplant Market Size #Corneal Transplant Market Overview #Corneal Transplant Market Forecast #Corneal Transplant Market Trends

1 note · View note

pranalipawarshinde · 2 years

Text

Neurotrophic Keratitis Market Prospects and Growth Assessment Report by 2027

Neurotrophic Keratitis Market: Introduction

Transparency Market Research has published a new report titled, “Global Neurotrophic Keratitis Market”. According to the report, the global neurotrophic keratitis market was valued at US$ 91.6 Mn in 2018 and is projected to expand at a CAGR of ~17% from 2019 to 2027. Rise in reported cases of keratitis, increase in research & developmental activities, surge in awareness, and rise in co-morbidities & risk factors boost the growth of the global neurotrophic keratitis market.

Request A Sample: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=72848

Pharmacotherapies using Drugs to Lead Global Market

In terms of treatment type, the drugs segment accounted for major share of the global neurotrophic keratitis market in 2018. The segment is anticipated to witness strong growth from 2019 to 2027. The drugs segment has been sub-segmented into artificial tears, recombinant human nerve growth factor eye drop, antibiotics, bandage contact lens, and others. The artificial tears sub-segment accounted for major share of the drugs segment in 2018. However, the recombinant human nerve growth factors eye drops sub-segment is expected to account for major share by 2027, as these eye drops restore the normal healing process of the eye and repair corneal damage. The drugs segment’s major market share is due to increase in clinical studies, approvals, and launch of various novel products. In February 2019, ReGenTree initiated the ARISE-3 study, the phase 3 clinical trial of the new drug RGN-259 for the treatment of dry eye syndrome. In August 2018, Dompé announced the U.S. Food and Drug Administration (FDA) approval for cenegermin (Oxervate), a breakthrough therapy for neurotrophic keratitis (NK), which is a rare and progressive eye disease that can lead to corneal scarring and vision loss.

Stage II Neurotrophic Keratitis to Remain Significant

Based on application, the stage I segment held major share of the global neurotrophic keratitis market in 2018. However, the stage II segment is projected to capture the largest share of the global market by 2027. Dominance of the stage I segment in 2018 can be ascribed to off-label availability of products for stage I, high prevalence of early symptoms in stage I, and high demand for preservative-free artificial tears during the first half of the forecast period. Symptoms of stage II neurotrophic keratitis help in diagnosis of the disease. A study published in 2014 titled, “Diagnosis and management of neurotrophic keratitis”, stated that stage II NK is characterized by recurrent and/or persistent epithelial defects (PED) with an oval or circular shape, most frequently localized at the superior half of the cornea. Diagnosis of NK is primarily based on the clinical history of conditions associated with trigeminal impairment, presence of PED or ulcers, and decreased corneal sensitivity.

A study published in Elsevier, Inc. in November 2017 indicated that around 34% of total studied patients in Italy were affected by persistent epithelial defects (PED) of stage II. Hence, the growth of the stage II segment can be ascribed to rise in awareness about and rate of diagnosis of the disease, launch of products which are effective in stage II persistent epithelial defects treatment, and surge in inclination of patients toward specialized centers for receiving advanced treatment.

Request Brochure: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=72848

Neurotrophic Keratitis Market: Prominent Regions

North America held the largest share of the global neurotrophic keratitis market in 2018. The market in the region is projected to grow at a rapid pace during the forecast period, driven by presence of key players, technological advancements, and highly structured healthcare industry. Increase in clinical trials, product launches, and approvals, and rise in investment by key players are projected to propel the neurotrophic keratitis market in North America. The U.S. is anticipated to dominate the neurotrophic keratitis market in the region during the forecast period, owing to early adoption of technologies. The country is expected to be the most attractive market for neurotrophic keratitis treatment products, with high attractiveness index. Well-equipped hospitals, technological advancements, rise in research & development on neurotrophic keratitis for novel treatment and appropriate cure, and surge in demand for novel products & treatments are likely to augment the neurotrophic keratitis market in the U.S.

Neurotrophic Keratitis Market: Key Players

Key players in the global neurotrophic keratitis market focus on strengthening their positions in the global market. Players are collaborating with other companies, actively conducting research studies, participating in mergers & acquisitions, and increasing product approvals and launches to secure and strengthen their positions in the global neurotrophic keratitis market. In April 2019, Neuroptika announced positive data from the company's phase 1 clinical trial to determine the safety, tolerability, and pharmacokinetics of topical NRO-1 in healthy subjects. NRO-1 is a novel therapeutic, with the potential to protect and regenerate corneal nerves in ophthalmic diseases. In July 2017, Dompé announced that the European Commission had granted marketing authorization of cenegermin eye drops for the treatment of moderate to severe neurotrophic keratitis.

Request for covid19 Impact Analysis: https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=72848

Major players operating in the global neurotrophic keratitis market include Dompe farmaceutici S.p.A., Allergan, ReGenTree, LLC, Alcon, Bausch & Lomb Incorporated (Bausch Health Companies Inc.), CONTACARE, ROHTO Pharmaceutical Co., Ltd., Pfizer, Inc., Neuroptika, Santen Pharmaceutical Co., Ltd., Johnson & Johnson, Grand Pharma (China) Co., Ltd., and Zhejiang CONBA Pharmaceutical Co., Ltd.

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of analysts, researchers, and consultants, uses proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research, 90 State Street, Suite 700, Albany, NY 12207 Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: [email protected] Website: https://www.transparencymarketresearch.com/

0 notes

mrfrblogresearch02 · 2 years

Text

Corneal Transplant Market Size, Scope, Growth, Competitive Analysis 2027

Market Highlights

According to MRFR, the Global Corneal Transplant market is expected to perceive exponential growth, registering CAGR of 10.8% during the forecast period.

The global market for Corneal Transplant is growing pervasively over last decade. Factors such as increasing prevalence injuries & diseases related to the eye/ sight that fuel the transplants cases are fuelling the market growth to an extent. Also the risk factors for the blindness & eye sight disorders are creating the demand for the better Corneal Transplants and treatment methods in turn, speed up the market growth.

Accrediting the kind of growth the market is witnessing and the growth prospect the market is demonstrating, Market Research Future (MRFR), has recently published a brilliant study report.

Major Players in Corneal Transplant Market:

Some of the key players in the global market are CryoLife, Inc. (U.S.), Exactech, Inc. (U.S.), Köhler GmbH (U.S.), Lifeline Scientific (U.S), LifeCell Corporation (U.S.), Medtronic (U.S.), and Organogenesis Inc. (U.S.).

Regional Analysis

Globally, Europe is the largest market for the corneal transplant rejection rate. Factors such as the availability of multiple treatment options, prevention strategy as well as rising influence of organ donation programs, coupled with the increased government emphasis on organ donation policies drive the regional growth of the market. Moreover, increasing prevalence of diabetes in the region are providing impetus to the market growth.

While North America region stands as the second-largest market for Corneal Transplant. This growth attributes to the increasing demand for corneal transplant surgery coupled with the growing prevalence of eye diseases, and vision impairment among people in the region drive the regional market growth. Moreover, growing Centers for Disease Control and Prevention, coupled with the age-related eye diseases such as age-related macular degeneration, cataract, diabetic retinopathy, and glaucoma are leading causes of blindness and vision imparity especially in the United States; such factors foster the regional market growth.

On the other hand the developing regions markets particularly Asia Pacific will be the fastest growing market for Corneal Transplant. Risk factors for the eye diseases such as the ever-increasing prevalence of chronic diseases such as diabetes, diabetic retinopathy, and obesity provide impetus to the growth of the regional market. Attributing to the availability of qualitative eye care treatment and skilled medical professionals, India has become one of the international medical tourism destinations across the world. This, in turn fuels the growth of corneal transplant market in India resultantly, fostering the growth of the APAC market.

Market Segmentation:

The global corneal transplant market is segmented on the basis of type, indication, and end user.

On the basis of type, the market is segmented into penetrating keratoplasty, endothelial keratoplasty, descemet stripping automated endothelial keratoplasty (DSAEK), corneal graft, corneal limbal stem cell transplant, and others.

On the basis of indication, the market is segmented into fungal corneal ulcer, bullous keratopathy, keratoconus, keratitis, corneal stromal dystrophies, and others.

On the basis of end user, the market is segmented into hospitals, eye clinics, and others.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: [email protected]

#Corneal Transplant Market

0 notes

numberonepeacetragedy · 3 years

Text

Corneal Transplant Market is to grow at approximately 10.8% CAGR by 2027

Market Highlights

Corneal transplant is a surgical procedure performed for the treatment of diseased cornea. Important indications for corneal transplant are keratoconus, keratitis, and corneal stromal dystrophies. The success rate of the treatment is found to be high, which support the market growth.

Rising prevalence of vision impartment and eye diseases such as diabetic retinopathy in geriatric population and diabetes across the globe drive the global market. Additionally, rising awareness about organ donation and its importance, especially, in the developing countries likely to propel the market growth.

Access Report Details @ https://www.marketresearchfuture.com/reports/corneal-transplant-market-4525

Cost of corneal transplant varies depending upon the region, availability of services, and skilled and qualified professionals. Major difference in the cost is observed, i.e. it is found to be high in the developed countries and low in developing countries still maintaining qualitative care. Therefore, cost effective of the treatment would affect the market growth.

The global Corneal Transplant Market is expected to grow at a CAGR of 10.8% during the forecast period.

Major Players in Corneal Transplant Market:

Some of the key players in the global market are CryoLife, Inc. (U.S.), Exactech, Inc. (U.S.), Köhler GmbH (U.S.), Lifeline Scientific (U.S), LifeCell Corporation (U.S.), Medtronic (U.S.), and Organogenesis Inc. (U.S.).

Regional Analysis

Europe is the largest market for corneal transplant which will exhibit positive growth in the near future due to rising prevalence of diabetes in the European countries and availability of treatment options. According to the World Health Organization, about 60 million Europeans have diabetes and its prevalence is relatively high among people over 25 years.

America is the second leading Corneal Transplant Market across the globe owing to an increasing demand for corneal transplant surgery, and rising prevalence of eye diseases, and vision impairment among people in the U.S.

Asia Pacific market is expected to grow rapidly owing increasing prevalence of chronic diseases such as diabetes, diabetic retinopathy, and obesity. India is one of the international medical tourism destinations across the world, which further exhibits growth opportunities for the Corneal Transplant Market due to availability of cost-effective treatment and rising success rates. Furthermore, the increasing healthcare expenditure by developing countries in Asia Pacific region also contributes to the market growth.

The Middle East & African market is growing steadily owing to rising demand for ophthalmic products and services, and available treatment options.

Segmentation

The global Corneal Transplant Market is segmented on the basis of type, indication, and end user.

On the basis of type, the market is segmented into penetrating keratoplasty, endothelial keratoplasty, descemet stripping automated endothelial keratoplasty (DSAEK), corneal graft, corneal limbal stem cell transplant, and others.

On the basis of indication, the market is segmented into fungal corneal ulcer, bullous keratopathy, keratoconus, keratitis, corneal stromal dystrophies, and others.

On the basis of end user, the market is segmented into hospitals, eye clinics, and others.

Request a Sample Report @

https://www.marketresearchfuture.com/sample_request/4525

NOTE: Our Team of Researchers are Studying Covid19 and its Impact on Various Industry Verticals and wherever required we will be considering Covid19 Footprints for Better Analysis of Market and Industries. Cordially get in Touch for More Details.

0 notes

marketreport · 4 years

Text

Corneal Ulcer Treatment Market Pegged for Robust Expansion During 2019-2029

An open source develops on the cornea, a thin membrane that lies over the iris. The most common cause of corneal ulcers is infection that includes bacterial, viral and fungal infection. Bacterial infection is the most common of them all. People who wear contact lenses are the most prone to infection and are most susceptible to corneal ulcers. Other risk factors include participation in activities that may result in damage to eye such as contact sports, exposure to chemicals and other eye conditions such as dry eye or Bell’s palsy. Corneal ulcers can be prevented by protecting the eyes, maintaining hygiene and following recommendations of the doctors prescribe especially ones who use contact lens. Corneal ulcers treatment must be given at earliest once diagnosed. Some of the symptoms corneal ulcers include pain and discharge from eyes along with sensation of foreign particle in the eye. Corneal ulcers treatment depends on the severity of the condition. In mild conditions, corneal ulcer treatment involves the use of cold compression and some non-prescription pain medicines to help with the discomfort. In severe conditions, the corneal ulcer treatment involves the treatment of the infection. Antibiotics, antifungals and antiviral eye drops are recommended corneal ulcer treatment based on the type of infection. In some cases the corneal ulcer treatment also included oral antifungal/antibiotics as corneal ulcer treatment market. These antibiotic corneal ulcer treatment products are available in the form of ointment that can be applied around the eye. In worse conditions the corneal ulcer treatment recommended is the surgical treatment. A corneal transplant is recommended to replace the damaged tissue with a healthy donor cornea tissue. Steroids and anti-inflammatory eye drops are generally prescribes once the infection subsides. However, the use of steroids as corneal ulcer treatment is controversial and is recommended to be used under close supervision since this form of corneal ulcer treatment can worsen an infection. Among all the corneal ulcer treatment options, oral medications and ointments are most commonly used. The corneal ulcer treatment products are available in hospital pharmacies, retail pharmacies, drug stores and e-commerce stores. Some of the common modes of corenal ulcer treatments include the use of prednisone, ciprofloxacin, ofloxcin and others. Some of the companies that manufacture the corneal ulcer treatments include Pfizer, Alcon Laboratories, INC., GlaxoSmithKline plc, Allergan PLC, Johnson & Johnson, Vistakon Pharmaceuticals, H.L. Healthcare among other key players.

To Get the Sample Copy of Report visit @https://www.futuremarketinsights.com/reports/sample/rep-gb-6953

Corneal Ulcer Treatment Market: Dynamics

Technological advancements and growing adoption of contact lenses are driving the growth of the corneal ulcers treatment market. The availability of soft lenses that can be used for longer duration is becoming more and more popular among contact lens users, however, use of contact lens for longer duration increases the risks of development of corneal ulcers. The increase in infectious diseases and poor hygiene in the emerging regions are the other driving factors for the growth of the corneal ulcers treatment market. Furthermore, growing awareness regarding corneal ulcer has resulted in increased diagnosis rate thereby driving the growth of the corneal ulcer treatment market.

Corneal Ulcer Treatment Market: Regional Outlook

On the basis of geography, the global corneal ulcer treatment market is segmented into seven key regions, namely North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan, and Middle East & Africa. North America is projected to hold large share in the global corneal ulcer treatment market primarily due to growing awareness about pelvic inflammatory disease, and improved healthcare scenario. The increased healthcare spending in North America is another factor driving the growth of the corneal ulcer treatment market.

Corneal Ulcer Treatment Market: Segmentation

The global pelvic inflammatory disease therapeutics market is segmented by administration, distribution channel and region:

Oral

Ointment

Eye Drops

Intravenous

Hospital Pharmacies

Retail Pharmacies

Drug Stores

E-Commerce

Corneal Ulcer Treatment Market: Key Players

Examples of some of the key players in the global pelvic inflammatory disease therapeutics market are Pfizer, Akorn Inc, Alcon Laboratories, INC., H.L. Healthcare, GlaxoSmithKline plc, Allergan PLC, Johnson & Johnson, Vistakon Pharmaceuticals, among other key players.

The report covers exhaustive analysis on:

Market Segments

Market Dynamics

Market Size

Current Trends/Issues/Challenges

Competition & Companies involved

Value Chain

The regional analysis includes:

North America (U.S., Canada)

Latin America (Mexico. Brazil)

Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)

Eastern Europe (Poland, Russia)

Asia-Pacific Excluding Japan (China, India, ASEAN, Australia & New Zealand)

Japan

The Middle East and Africa (GCC, S. Africa, N. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Report Highlights:

Detailed overview of parent market

Changing market dynamics in the industry

In-depth market segmentation

Historical, current and projected market size in terms of volume and value

Recent industry trends and developments

Competitive landscape

Strategies of key players and products offered

Potential and niche segments, geographical regions exhibiting promising growth

A neutral perspective on market performance

Research Methodology

FMI utilizes a triangulation methodology that is primarily based on experimental techniques such as patient-level data, to obtain precise market estimations and insights on Molecule and Drug Classes, API Formulations and preferred modes of administration. Bottom-up approach is always used to obtain insightful data for the specific country/regions. The country specific data is again analysed to derive data at a global level. This methodology ensures high quality and accuracy of information.

Secondary research is used at the initial phase to identify the Age specific disease epidemiology, diagnosis rate and treatment pattern, as per disease indications. Each piece of information is eventually analysed during the entire research project which builds a strong base for the primary research information.

Primary research participants include demand-side users such as key opinion leaders, physicians, surgeons, nursing managers, clinical specialists who provide valuable insights on trends and clinical application of the drugs, key treatment patterns, adoption rate, and compliance rate.

Ask an Analyst @https://www.futuremarketinsights.com/ask-question/rep-gb-6953

Quantitative and qualitative assessment of basic factors driving demand, economic factors/cycles and growth rates and strategies utilized by key players in the market is analysed in detail while forecasting, in order to project Year-on-Year growth rates. These Y-o-Y growth projections are checked and aligned as per industry/product lifecycle and further utilized to develop market numbers at a holistic level.

On the other hand, we also analyse various companies annual reports, investor presentations, SEC filings, 10k reports and press release operating in this market segment to fetch substantial information about the market size, trends, opportunity, drivers, restraints and to analyse key players and their market shares. Key companies are segmented at Tier level based on their revenues, product portfolio and presence.

Please note that these are the partial steps that are being followed while developing the market size. Besides this, forecasting will be done based on our internal proprietary model which also uses different macro-economic factors such as per capita healthcare expenditure, disposable income, industry based demand driving factors impacting the market and its forecast trends apart from disease related factors.

#market analysis #market trends

0 notes

researchtrendingmarket-blog · 4 years

Text

Persistent Corneal Epithelial Defects Treatment Market Shows Strong Growth| Novartis AG, Allergan, Johnson & Johnson Services Inc.

Persistent Corneal Epithelial Defects Treatment Market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Asia Pacific Persistent corneal epithelial defects treatment market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with a stronger CAGR of 4.1% in the forecast period of 2020 to 2027 and expected to reach USD 224.64 million by 2027.

Get Sample Report at :

https://www.databridgemarketresearch.com/request-a-sample/?dbmr=asia-pacific-persistent-corneal-epithelial-defects-treatment-market

Competitive Analysis: Asia-Pacific Persistent Corneal Epithelial Defects Treatment Market

Few of The major players covered in the Asia-Pacific Persistent Corneal Epithelial Defects Treatment Market are Novartis AG, Allergan, Johnson & Johnson Services, Inc., Laboratoires THEA S.A.S, Almirall, S.A, Bausch Health, Integra LifeSciences Corporation among other players in Asia-Pacific. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Key Pointers Covered in the Asia-Pacific Persistent Corneal Epithelial Defects Treatment Market Trends and Forecast to 2026

Asia-Pacific Persistent Corneal Epithelial Defects Treatment Market New Sales Volumes

Asia-Pacific Persistent Corneal Epithelial Defects Treatment Market Replacement Sales Volumes

Asia-Pacific Persistent Corneal Epithelial Defects Treatment Market Installed Base

Asia-Pacific Persistent Corneal Epithelial Defects Treatment Market By Brands

Asia-Pacific Persistent Corneal Epithelial Defects Treatment Market Size

Asia-Pacific Persistent Corneal Epithelial Defects Treatment Market Procedure Volumes

Asia-Pacific Persistent Corneal Epithelial Defects Treatment Market Product Price Analysis

Asia-Pacific Persistent Corneal Epithelial Defects Treatment Market Healthcare Outcomes

Asia-Pacific Persistent Corneal Epithelial Defects Treatment Market Cost of Care Analysis

Asia-Pacific Persistent Corneal Epithelial Defects Treatment Market Regulatory Framework and Changes

Asia-Pacific Persistent Corneal Epithelial Defects Treatment Market Prices and Reimbursement Analysis

Asia-Pacific Persistent Corneal Epithelial Defects Treatment Market Shares in Different Regions

Recent Developments for Asia-Pacific Persistent Corneal Epithelial Defects Treatment Market Competitors

Asia-Pacific Persistent Corneal Epithelial Defects Treatment Market Upcoming Applications

Asia-Pacific Persistent Corneal Epithelial Defects Treatment Market Innovators Study

Get Detailed TOC:

https://www.databridgemarketresearch.com/toc/?dbmr=asia-pacific-persistent-corneal-epithelial-defects-treatment-market

Scope of the Persistent Corneal Epithelial Defects Treatment Market

Based on clinical causes, the market is segmented into epithelial/limbal stem cell deficiency, inflammatory disease, neurotrophic keratitis (NK) and others. Inflammatory diseases segment is dominating in the persistent corneal epithelial defects treatment market because inflammatory disease is one of the most common cause of persistent corneal epithelial disease (PCED) and high usage of medication as well as devices in the treatment. Additionally, the increasing demand of dry eye and other inflammatory diseases treatment is expected to help the market to grow significantly. According ScienceDirect Article, in Japan the direct cost analysis of medical and drug costs (which includes costs for artificial tear use and punctal plugs) the total annual cost per patient is USD 530.

On the basis of type, the market is segmented into devices and medication. Although lubricant eye drops are the first line treatment for the PCED treatment, are generally insufficient to treat PCED. Very few pharmaceutical products are available for the persistent corneal epithelial defects treatment. Additionally, the medical device are more effective treatment options for the PCED treatment, such as bandage contact lens and amniotic membranes are more effective option PCED treatment.

Market Segmentation: Asia-Pacific Persistent Corneal Epithelial Defects Treatment Market

Persistent corneal epithelial defect is a multifactorial disorder occurs due to failure of corneal epithelialization mechanism which leads to the disturbance in the corneal surface and exposed the eyes vulnerable to the stromal ulceration, herpetic infections and scarring. Growing Ageing Population Augmenting towards the PCED condition is augmenting the market growth.

Increasing prevalence of persistent corneal epithelial defect production is driving the growth of market. Growing ageing population augmenting towards the PCED condition will also drive the market. For instance in 2018, World Health Organization projected that there were 39.71 million geriatric populations in Russia by the year 2050. Increasing awareness about diagnosis and treatment of the disease will further create new opportunities that will impact this persistent corneal epithelial defects treatment market growth in the forecast period to 2027.

This persistent corneal epithelial defects treatment market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Reasons to Purchase this Report:

The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.

Regions/Countries that are expected to witness the fastest growth rates during the forecast period.

The latest developments, market shares, and strategies that are employed by the major market players.

Speak to Author :

https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=asia-pacific-persistent-corneal-epithelial-defects-treatment-market

Key insights in the report:

Complete and distinct analysis of the market drivers and restraints

Key Market players involved in this industry

Detailed analysis of the Market Segmentation

Competitive analysis of the key players involved

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: [email protected]

Browse Related Report Here:

Monoclonal Antibodies Market

Plaque Psoriasis Market

#Persistent Corneal Epithelial Defects Treatment Market #Persistent Corneal Epithelial Defects Treatment Market share #Persistent Corneal Epithelial Defects Treatment Market size #Persistent Corneal Epithelial Defects Treatment Market trends #Persistent Corneal Epithelial Defects Treatment Market news #Persistent Corneal Epithelial Defects Treatment Market report #Persistent Corneal Epithelial Defects Treatment Market growth #Persistent Corneal Epithelial Defects Treatment Market forecast

0 notes

rohans18 · 1 year

Text

Corneal Ulcer Treatment Market Share, Size, Research, CAGR, and Growth - Forecast 2029

Global Corneal Ulcer Treatment Market, By Treatment (Medication, Surgery, Others), Diagnosis (Fluorescein Eye Stain Test, Slit-Lamp Exam, Others), Symptoms (Redness, Tears, Discharge from Eye, Blurry Vision, Swollen Eyelids, Vision Changes, Severe Pain, Others), Dosage (Eye Drops, Tablets, Others), Route of Administration (Oral, Topical, Others), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) Industry Trends and Forecast to 2029

The consistent Corneal Ulcer Treatment market report analyzes many points that help businesses to solve the toughest questions in less time. The major topics of this business report are global growth trends, market share by manufacturers, market size by type, market size by application, production by region, consumption by region, company profiles, market forecast, value chain and sales channels analysis, opportunities & challenges, threat and affecting factors. The report gives market definition in the form of market driving factors and market restraints which helps estimating the demand of particular product depending on several aspects. Corneal Ulcer Treatment market survey report studies the global market status and forecast, categorizes the global market size, market value & market volume by key players, type, application, and region.

Key Players

Some of the major players operating in the corneal ulcer treatment market are Pfizer Inc., GlaxoSmithKline plc, Sanofi, Novartis AG, Allergan, Merck & Co., Inc., Mylan N.V., Teva Pharmaceutical Industries Ltd., Bayer AG, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, Lupin, AbbVie Inc., Cumberland Pharmaceuticals Inc., Melinta Therapeutics LLC, Eli Lilly and Company, Cipla Inc., Dr. Reddy’s Laboratories Ltd., AstraZeneca, and Johnson & Johnson Private Limited, among others.

Browse More Info @ https://www.databridgemarketresearch.com/reports/global-corneal-ulcer-treatment-market

One of the principal objectives of a high-ranking Corneal Ulcer Treatment industry report is to analyze and study the global sales, value, status, and forecast. The market report also analyzes the global and key regions market potential and advantage, opportunity and challenge, restraints and risks. The report assists to define, describe and forecast the market by type, application and region. It estimates the region that is foretold to create the most number of opportunities in the global Corneal Ulcer Treatment market. This market research report comprises of estimations of CAGR values which are quite significant and aids businesses to decide upon the investment value over the time period. An insightful Corneal Ulcer Treatment market report assists clients to stay ahead of the time and competition.

Key questions answered in the report:

Which product segment will grab a lion’s share?

Which regional market will emerge as a frontrunner in coming years?

Which application segment will grow at a robust rate?

Report provides insights on the following pointers:

Market Penetration: Comprehensive information on the product portfolios of the top players in the Corneal Ulcer Treatment Market.

Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the market.

Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.

Table Of Content

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03: Global Market

Part 04: Global Market Sizing

Part 05: Global Market Segmentation By Product

Part 06: Five Forces Analysis

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: [email protected]

0 notes

tritonmarketresearch · 2 years

Text

Amniotic Membrane Market: Significance & Global Performance

Amniotic membrane or amnion, a thin membrane on the inner side of the fetal placenta and composed of the epithelium, has emerged as an ideal source for tissue transplantation. Moreover, amnion has an array of biological properties, making it attractive for use in various surgical procedures, including ocular surface reconstruction and tissue engineering.

The advancements in anatomy have triggered significant investments in research and development of amniotic membrane applications. While AM has shown beneficial results in burn injuries, the upsurge in R&D investments has increased its use in eye surgery, cell therapy, stem cell research, and more, boosting the amniotic membrane market growth prospects.

In fact, the identification of new stem cells has increased the membrane’s potential, making it ideal for developing regenerative medicines. For instance, Organogenesis Holdings Inc, a leading regenerative medicine company, gained approval from the US FDA for ReNu, a cryopreserved amniotic suspension allograft, to manage symptoms related to knee osteoarthritis.

Amniotic Membrane Market - Global & Regional Trends

As per estimates, the global amniotic membrane market will display revenue growth at a CAGR of 7.01% during the forecast period 2022-2028.

Considering the evolving healthcare sector, the amniotic membrane market is expected to witness tremendous growth in the Asia-Pacific nations. Estimates suggest that approximately half a billion people in the region will be 65 or older by 2025. This change in demographics, in addition to a shift in consumer expectations, will widen the market’s scope. In this regard, the growing demand for chronic care management will expand amnion application in ophthalmology, burn injuries, and cosmetic surgeries, among others.

Additionally, amniotic membrane transplantation has gained momentum in various conjunctival and corneal diseases, signaling opportunistic growth for players in the APAC region. Considering its growth in North America, amnions have proven advantageous in treating limbal stem cell deficiency, providing support and protection to transplanted limbal tissues and stem cells. Recently, in Canada, numerous techniques have been developed to dehydrate amnion while preserving the wound-healing properties to formulate a temperature-stable allograft.

Furthermore, the United Kingdom is the center of research and development of amniotic membrane applications in Europe. Several hospitals, such as NuVision, have gained expertise in providing AM treatments. Amniotic membrane treatments are gaining center stage across the nation, given the technological advancements. For instance, in November 2021, several ophthalmologists shared their innovations of AM application in treating ocular surface conditions through a webinar sponsored by NuVision Biotherapies Ltd.

Market by Application – Expert Outlook

Surgical Wounds: Human amniotic membrane has been used for treating acute and chronic wounds, decreasing infection and pain while accelerating the healing time. The surgical wound segment dominates the overall market and is expected to maintain its stronghold till 2028. Although a plethora of wound dressings are available, chronic wounds remain a major medical concern. As a result, chronic wounds awareness programs largely support amnion application. For instance, the Wound Healing and Hyperbaric Center at Carteret Health Care, a Healogic Network member, is engaged in raising awareness of chronic wounds, providing advanced therapies.

Ophthalmology: The rise in chronic and infectious diseases has resulted in a global rise in surgeries, boosting the market’s potential. Amniotic membrane is rapidly used in ophthalmic surgeries to initiate faster recovery and decrease inflammation. Amnion has become crucial in eye treatments, given its anti-scarring and anti-inflammatory properties. For instance, Bio Tissue Inc offers AmnioGraft to treat ocular surface indications like corneal ulcers, dry eye, chemical burns, etc. Besides, AM is highly preferred in developing regions since it is cheaper than allografts.

Competitive Analysis

For any company, acquisitions and agreements ensure expansion in business footings. Acquisitions, for instance, are quicker, cheaper, and less risky compared to other methods to extend volume sales. On the other hand, agreements are crucial to eliminating disagreements, confusion, or changes that may transpire during the course of the business period.

Notable acquisitions and agreements that support the market’s development:

In February 2021, Katena Products Inc, a leading provider of premium ophthalmic instruments and devices, announced the acquisition of ASICO LLC to expand the ophthalmic surgical product line and lead in the innovation of new products.

Integra LifeSciences Corporation, in January 2021, acquired ACell Inc and its proprietary MatriStem UMB to offer comprehensive wound management solutions.

Celularity Inc and Oncternal Therapeutics Inc entered into a research partnership in September 2021 to examine placental-derived cellular treatments.

Celularity also collaborated with Imugene Ltd in August 2021 to employ Imugene’s CD19 oncolytic virus technology and its CD19 CYCART-19 to remedy solid tumors.

In Conclusion,

The amniotic membrane market has shown rapid and promising results in healing damaged tissues. From chemical burns to ulcers to the cornea, amnions have emerged as suitable membranes in wound care management. This indicates that the use of AM in medicine and therapies is expanding in various branches of medicine.

#Amniotic Membrane Market #amniotic membrane #healthcare #wellness #lifesciences #market research #triton market research #market research reports

0 notes

kennethresearch · 3 years

Text

Global Contact Lenses Market Share, Application, Analysis, Regional Outlook, Growth, Trends and Forecasts 2021

Contact lenses are one of the modern addition to eye care. It is a thin curved lens which is placed on the surface of the eye. Generally, they are substitutes for wearing glasses though there might be other reasons, aesthetics and cosmetics are the two main motivating factor for people to change the appearance of the eyes or to avoid wearing eyeglasses. Other reasons include functional or optical reason which makes contact lenses preferable for outdoor activities or sports. Contact lenses are either of the type hard or soft but the latter is worn by most people nowadays. Contact lenses generally have various lifetimes which needs to be disposed of after a specific time of usage ranging from a day to a year depending on the type used.

Get Sample Reports Here - https://www.kennethresearch.com/sample-request-10064912

Market Dynamics

The growing usage of corrective contact lenses for treatment of visual deficiencies like myopia, hypermetropia, astigmatism etc. drive the global market of contact lenses over the forecast period of 2017-2024. The market for global contact lenses was valued at USD XX billion in 2016 and is expected to maintain its growth rate over the forecast period and reach USD XX billion by 2025. One of the prominent contributors to the market share is the use of soft lenses which provides various applications to the contact lenses market. One of the leading industry segments over the forecast period is anticipated to be the spherical lens segment which accounted for XX% of the industry share in 2014. Also, the demand for torric lens is expected to increase substantially with a CAGR of XX% over the forecast period.

Few drivers which are leading to the fast growth of the market are the rising tendency of young people to enhance their personal appearance, also the growing geriatric population and changing lifestyles. Economic factors like improvement in overall economy rising disposable income over the globe also act as additional factors for the growth of this market. However, the increased risk of eye infections and corneal ulcers pulls back the growth and hence instead of contact lens few people prefer normal eyeglasses.

Market Segmentation

The market is segmented in terms of product outlook, design outlook, and usage outlook. By product outlook, the lens can be segmented into RPG Lens, Soft lens, Hybrid Lens. By design outlook, the contact lenses market is divided into spherical,torric, multifocal, others. As per usage outlook, the market can be segmented into corrective, therapeutic,cosmetic,prosthetic, lifestyle oriented.

Regional/Geographical Analysis

Various regions around the globe have shown an increased adoption of the usage of contact lenses. The South American and Asia Pacific market will show an immense growth in the forecast period whereas Chinese regional market is also witnessing a significant growth in the cosmetic lens segment.The main manufacturing units of contact lenses are in Asia but it has also made inroads in the U.S. regions as well. The Japanese regional market is also expected to show increased growth prospects with increased usage of lens for cosmetic reasons

Key Players

Some of the major players in the market include Johnson and Johnson Services, Bausch and Lomb, CIBA Vision (Alcon) and Cooper Vision. Report ContentsRegional AnalysisReport Highlights

Market segments

Market Drivers, Restraints and Opportunities Market Size & Forecast 2016 to 2022 Supply & Demand Value Chain Market - Current Trends Competition & Major Companies Technology and R&D Status Porters Five Force Analysis Strategic and Critical Success Factor Analysis of Key Players

About Kenneth Research

Kenneth Research is a reselling agency providing market research solutions in different verticals such as Automotive and Transportation, Chemicals and Materials, Healthcare, Food & Beverage and Consumer Packaged Goods, Semiconductors, Electronics & ICT, Packaging, and Others. Our portfolio includes set of market research insights such as market sizing and market forecasting, market share analysis and key positioning of the players (manufacturers, deals and distributors, etc), understanding the competitive landscape and their business at a ground level and many more. Our research experts deliver the offerings efficiently and effectively within a stipulated time. The market study provided by Kenneth Research helps the Industry veterans/investors to think and to act wisely in their overall strategy formulation

Contact Us

Name: David

Email: [email protected]

Phone: +1 313 462 0609

1412, Broadway,

21st Floor Suite MA111,

New York, NY 10018

0 notes

supermarkettrends · 4 years

Text

Persistent Corneal Epithelial Defects Treatment Market Strategic Insights and key Business Influencing Factors | Major Players – Novartis AG, Allergan, Johnson & Johnson Services Inc.